Considering hydroxyurea is a potent mutagen, breastfeeding should perhaps be avoided for 1224 h after receiving a dose. As renal excretion is a pathway of elimination, consideration should be given to decreasing the dosage of hydroxyurea in patients with renal impairment. Reduce the dose from the dose associated with hematologic toxicity. Patients with acute myeloid leukemia aml and hyperleukocytosis are at high risk of early mortality due to pulmonary, renal, and central nervous system complications. Renal drug handbook 3rd edition general intensive care unit. Hydrea hydroxyurea dose, indications, adverse effects. Hydroxyurea dose and toxicity in african american patients. This chapter is dedicated to the dosing of medications in patients with chronic kidney. Hydroxyurea oral capsule hydrea, droxia is used to treat certain cancers and sickle cell disease. Hydroxyurea is not approved by the fda for use in children with sickle cell disease. This book consists of a brief introductory chapter con taining a discussion of drug ther apy in patients with renal. Close monitoring of hematologic parameters is advised in these patients. Seyffarts directory of drug dosage in kidney disease.
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sicklecell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. Hydroxyurea in the early management of acute myeloid. Uclh dosage adjustment for cytotoxics in renal impairment version 3 updated january2009 page 2 of 24 dosage adjustment for cytotoxics in renal impairment this table is a guide only. Obtain the creatinine clearance using a 24hour urine collection. Aronoff gr, bennett wm, berns js, et al, drug prescribing in renal failure. Use of this medication in children with sickle cell disease is recommended by the nhlbi guidelines published in jama cited in reference 1. The safety and the proper dosage of this agent in sickle cell patients with impaired renal function have not been well studied in the clinical setting. For patients with severe renal insufficiency crcl 3. This guide succeeds at providing busy healthcare providers with updated and evidencebased information on dosing and monitoring commonly used medications in patients with renal dysfunction.
The purpose of our study was to evaluate hu dose and hematological toxicity in adult african american patients with sickle cell disease and impaired renal. Hydroxyurea enters human breast milk with a relative infant dose of about 4. Reduce the dose of droxia by 50% in patients with creatinine clearance of less than 60 mlmin or with endstage renal disease esrd see use in specific populations and clinical pharmacology. At exit children treated with hydroxyurea had significantly higher urine osmolality mean 495 mosmkg h2 o compared to 452 in the placebo group, p 0. Renal pharmacotherapy is a comprehensive listing of dosage recommendations for patients with compromised renal function. Public users are able to search the site and view the abstracts for each book. Hydrea hydroxyurea capsules, usp is an antimetabolite available for oral use as capsules containing 500 mg hydroxyurea. Renal dosage adjustment guidelines for antimicrobials. Hydroxyurea hu is the first approved pharmacological treatment of sickle cell anemia sca. The patient should be at a stable dose with no hematologic toxicity for 24 weeks. Adult drugs analgesics antihypertensive and cardiovascular agents antimicrobial agents miscellaneous agents sedatives, hypnotics, and other drugs used in. Leukapheresis and low dose continuous infusion of cytarabine and hydroxyurea hu have been used but their advantages and limitations are not well characterized. The objectives of this study were to develop population pharmacokineticpkpharmacodynamicpd models for hu in order to characterize the exposureefficacy relationships and their variability, compare two dosing regimens by simulations and develop some recommendations for. Started in 1995, this collection now contains 6769 interlinked topic pages divided into a tree of 31 specialty books and 732 chapters.
In sicklecell disease it increases fetal hemoglobin and decreases the number of attacks. Except for patients with esrd, all the patients received a 15. Hydroxyurea uses, side effects, substitutes, composition. Hydroxycarbamide drug bnf content published by nice. Dosage and administration individualize treatment based on tumor type, disease state, response to treatment, patient risk factors, and current clinical practice standards.
Hydroxyureabased treatment for pediatric patients with. Hydroxyurea for children with sickle cell anemia in sub. The effect of renal impairment on the pharmacokinetics of hydroxyurea was assessed in adult patients with sickle cell disease and renal impairment. Hydroxyurea for the treatment of psoriasis including in. This new book addresses the persistent and challenging problem of dosing medications for patients with renal insufficiency and dysfunction. Oral dosage siklos only children and adolescents 2 to 17 years. Hydroxyurea is an oral medicene that is prescribed to patients suffering from chronic myelogenous leukemia, acute myelogenous leukemia, sicklecell disease, ovarian cancer, cervical cancer, and polycythemia vera this medicine slows down the growth of cancer cells in the body and can reduce the need for blood tranfusion. Drug dosing adjustments in patients with chronic kidney. Further, recent studies have shown that improper dosing in patients with renal dysfunction occurs over 20% of the time. This uptodate and evidencebased reference closes several identified knowledge gaps concerning medications eliminated by the kidneys. Hydroxyurea and are likely due to the chronic cumulative toxicity of hydroxyurea or one of its metabolites. There are no data that support specific guidance for dosage adjustment in patients with renal impairment.
Learn about side effects, warnings, dosage, and more. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath. Drug dosing adjustments in patients with chronic kidney disease myrna y. Hydroxyurea was then continued in the patients where hydroxyurea was beneficial. After 6 months of treatment, the hydroxyurea dose was escalated by 2. Clinical course of haemodialysis patients with malignancies and dose adjusted chemotherapy.
Pharmacokinetic, summary of product characteristics spc, relevant pharmaceutical company data and various references have been. Your dose will be based on your weight, medical condition, and response to treatment. Further information can be found in clinical pharmacology textbooks such as begg. The information on dosage adjustments in renal impairment given in this book is based on cockcroftgault creatinine clearance and not egfr, since the majority. The pharmacists will automatically adjust the doses of any of the antimicrobials included in the protocol according to the estimated creatinine clearance generally using the cockroftgault equation for patients. Medication dose adjustments should be made as renal functions improves, including adjusting. Acute and chronic renal failure are the two kinds of kidney failure. Recommendations for dose modifications are not limited to adjustments based on declining renal function. Drug dosing in chronic kidney disease oxford medicine. Find comprehensive medical reference information including disease symptoms, diagnoses, treatments, and followup. In one study n 15, hydroxyurea was initiated at a dosage of 10 to 20 mgkgday and doses were titrated as tolerated mean dose 21. Munar, pharmd, bcps, and harleen singh, pharmd oregon state university college of pharmacy, portland, oregon. The term renal failure denotes the inability of the kidneys to perform excretory function. Dosing guidelines book school of medicine university of louisville.
Moreover, children treated with hydroxyurea had smaller renal volumes p 0. A catalogue record for this book is available from the british library. Use with other myelosuppressive agents or radiation may increase the likelihood of bone marrow depression or other adverse. Hydroxycarbamide is the main agent used to increase hbf box 65. This book is distributed under the terms of the creative commons. See important safety information and boxed warning about myelosuppression and malignancies. Dosage adjustment for cytotoxics in renal impairment. Hydroxyurea capsules these highlights do not include all.
Therapy should be initiated 7 days prior to radiation and. Monitor full blood count before treatment, and repeatedly throughout use. Drug doses should usually be reduced in renal disease in proportion to the. Specific pharmacologic considerations in the setting of renal insufficiency. The renal drug handbook the st georges hospital, adult critical. This guideline provides dose adjustments for adults based upon the degree of renal impairment or the need for hemodialysis or peritoneal dialysis. Creatinine clearance values were obtained using 24hour urine collections.
Renal functionbased dose adjustments adult inpatient. Hydroxyurea hydrea, droxia is a prescription drug used to treat several types of cancer including types of leukemia, head and neck cancer, malignant melanoma, and ovarian cancer. The drugs which are in bold, details of dose reductions are mentioned below table, scroll down. Population pharmacokinetics and pharmacodynamics of. Reduce the dose of hydroxyurea capsules by 50% in patients with measured creatinine clearance of less than 60 mlmin or with endstage renal disease esrd see use in specific populations 8.
In 1970 leavell and yarbro 5 conducted a crossover doubleblinded study where 10 patients with recalcitrant psoriasis were treated with either placebo or hydroxyurea 500mg bid for the first 4 weeks and then switched to the other arm for the following 4 weeks. Dosing guidelines for adults and children, 5th, american college of physicians, 2007. It comes as a capsule that is usually taken once in a day. Monitor renal and hepatic function before and during treatment. Patients with normal renal function creatinine clearance crcl 80 mlmin, mild crcl 50. The authors make no claims of the accuracy of the information contained herein.
156 659 218 1234 1228 296 201 1122 633 91 883 983 31 468 967 609 62 1384 665 535 238 964 437 1353 1432 247 1128 1131 635 1476 881 847 158 132